Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives.
Falanga A, Gal GL, Carrier M, Abdel-Razeq H, Ay C, Martin AJM, Rocha ATC, Agnelli G, Elalamy I, Brenner B.
Falanga A, et al. Among authors: abdel razeq h.
TH Open. 2021 Aug 31;5(3):e376-e386. doi: 10.1055/s-0041-1736037. eCollection 2021 Jul.
TH Open. 2021.
PMID: 34485812
Free PMC article.
Increased risk of recurrent VTE and bleeding complications are two major challenges associated with therapeutic anticoagulation in these patients. Long-term therapy with low-molecular-weight heparins (LMWHs) has been the standard of care for the treatment of cancer-associa …
Increased risk of recurrent VTE and bleeding complications are two major challenges associated with therapeutic anticoagulation in these pat …